Martin Shkreli (Shutterstock)
Martin Shkreli continued to orchestrate anti-competitive schemes for Daraprim behind bars — FTC
Martin Shkreli didn’t just blog, read up on drug development news and run his biotech business with a contraband cell phone in prison …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
